Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases

Daisuke Ito, Takuya Yagi, Norihiro Suzuki

Research output: Contribution to journalArticle

Abstract

In 2006, Takahashi et al. established a method for reprogramming somatic cells by introducing definite transcription factors, which enabled the generation of induced pluripotent stem cells (iPSCs) with pluripotency comparable to that of embryonic stem cells. In turn, it has become possible to use these iPSCs for producing various tissues needed for the treatment of neurodegenerative disorders, which have been difficult to obtain from living bodies. This advancement is expected to bring forth rapid progress in the clarification of mechanisms underlying the diseases and discovery of new innovative drugs and lead to rapid progress in regenerative medicine. In recent years, recapitulation and analysis of disease conditions using iPSCs derived from the patients themselves have been reported, and remarkable advances have been made, even for late-onset neurodegenerative disorders. These findings show that the phenotypes of late-onset neurodegenerative disorders can be recapitulated in iPSC-derived neuronal cells, which are reflected the early developmental stages, indicating cellular abnormalities exist from the prenatal period, despite the lateonset diseases. In this review, we summarize the state of iPSCs research in the context of neurodegenerative disorders, discuss the possible ways for understanding the mechanisms underlying neurodegenerative disorders and discovering new drugs, and describe some other aspects of regenerative medicine.

Original languageEnglish
Pages (from-to)283-286
Number of pages4
JournalBrain and Nerve
Volume65
Issue number3
Publication statusPublished - 2013 Mar

Fingerprint

Stem Cell Research
Induced Pluripotent Stem Cells
Neurodegenerative Diseases
Regenerative Medicine
Embryonic Stem Cells
Pharmaceutical Preparations
Transcription Factors
Phenotype

Keywords

  • Alzheimer disease
  • Centenarian
  • Induced pluripotent stem cell
  • Neurodegeneration
  • Parkinson disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases. / Ito, Daisuke; Yagi, Takuya; Suzuki, Norihiro.

In: Brain and Nerve, Vol. 65, No. 3, 03.2013, p. 283-286.

Research output: Contribution to journalArticle

Ito, Daisuke ; Yagi, Takuya ; Suzuki, Norihiro. / Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases. In: Brain and Nerve. 2013 ; Vol. 65, No. 3. pp. 283-286.
@article{85aab6ef14f14c9cbf1e338c7b050f9f,
title = "Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases",
abstract = "In 2006, Takahashi et al. established a method for reprogramming somatic cells by introducing definite transcription factors, which enabled the generation of induced pluripotent stem cells (iPSCs) with pluripotency comparable to that of embryonic stem cells. In turn, it has become possible to use these iPSCs for producing various tissues needed for the treatment of neurodegenerative disorders, which have been difficult to obtain from living bodies. This advancement is expected to bring forth rapid progress in the clarification of mechanisms underlying the diseases and discovery of new innovative drugs and lead to rapid progress in regenerative medicine. In recent years, recapitulation and analysis of disease conditions using iPSCs derived from the patients themselves have been reported, and remarkable advances have been made, even for late-onset neurodegenerative disorders. These findings show that the phenotypes of late-onset neurodegenerative disorders can be recapitulated in iPSC-derived neuronal cells, which are reflected the early developmental stages, indicating cellular abnormalities exist from the prenatal period, despite the lateonset diseases. In this review, we summarize the state of iPSCs research in the context of neurodegenerative disorders, discuss the possible ways for understanding the mechanisms underlying neurodegenerative disorders and discovering new drugs, and describe some other aspects of regenerative medicine.",
keywords = "Alzheimer disease, Centenarian, Induced pluripotent stem cell, Neurodegeneration, Parkinson disease",
author = "Daisuke Ito and Takuya Yagi and Norihiro Suzuki",
year = "2013",
month = "3",
language = "English",
volume = "65",
pages = "283--286",
journal = "Brain and Nerve",
issn = "0006-8969",
publisher = "Igaku-Shoin Ltd",
number = "3",

}

TY - JOUR

T1 - Progress in induced pluripotent stem cell research for age-related neurodegenerative diseases

AU - Ito, Daisuke

AU - Yagi, Takuya

AU - Suzuki, Norihiro

PY - 2013/3

Y1 - 2013/3

N2 - In 2006, Takahashi et al. established a method for reprogramming somatic cells by introducing definite transcription factors, which enabled the generation of induced pluripotent stem cells (iPSCs) with pluripotency comparable to that of embryonic stem cells. In turn, it has become possible to use these iPSCs for producing various tissues needed for the treatment of neurodegenerative disorders, which have been difficult to obtain from living bodies. This advancement is expected to bring forth rapid progress in the clarification of mechanisms underlying the diseases and discovery of new innovative drugs and lead to rapid progress in regenerative medicine. In recent years, recapitulation and analysis of disease conditions using iPSCs derived from the patients themselves have been reported, and remarkable advances have been made, even for late-onset neurodegenerative disorders. These findings show that the phenotypes of late-onset neurodegenerative disorders can be recapitulated in iPSC-derived neuronal cells, which are reflected the early developmental stages, indicating cellular abnormalities exist from the prenatal period, despite the lateonset diseases. In this review, we summarize the state of iPSCs research in the context of neurodegenerative disorders, discuss the possible ways for understanding the mechanisms underlying neurodegenerative disorders and discovering new drugs, and describe some other aspects of regenerative medicine.

AB - In 2006, Takahashi et al. established a method for reprogramming somatic cells by introducing definite transcription factors, which enabled the generation of induced pluripotent stem cells (iPSCs) with pluripotency comparable to that of embryonic stem cells. In turn, it has become possible to use these iPSCs for producing various tissues needed for the treatment of neurodegenerative disorders, which have been difficult to obtain from living bodies. This advancement is expected to bring forth rapid progress in the clarification of mechanisms underlying the diseases and discovery of new innovative drugs and lead to rapid progress in regenerative medicine. In recent years, recapitulation and analysis of disease conditions using iPSCs derived from the patients themselves have been reported, and remarkable advances have been made, even for late-onset neurodegenerative disorders. These findings show that the phenotypes of late-onset neurodegenerative disorders can be recapitulated in iPSC-derived neuronal cells, which are reflected the early developmental stages, indicating cellular abnormalities exist from the prenatal period, despite the lateonset diseases. In this review, we summarize the state of iPSCs research in the context of neurodegenerative disorders, discuss the possible ways for understanding the mechanisms underlying neurodegenerative disorders and discovering new drugs, and describe some other aspects of regenerative medicine.

KW - Alzheimer disease

KW - Centenarian

KW - Induced pluripotent stem cell

KW - Neurodegeneration

KW - Parkinson disease

UR - http://www.scopus.com/inward/record.url?scp=84875826237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875826237&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 283

EP - 286

JO - Brain and Nerve

JF - Brain and Nerve

SN - 0006-8969

IS - 3

ER -